Your browser doesn't support javascript.
loading
Rapid identification of an HLA-B*1501-restricted vaccinia peptide antigen.
Meyer, Ralf G; Graf, Claudine; Britten, Cedrik M; Huber, Christoph; Wölfel, Thomas.
Afiliación
  • Meyer RG; III Medizinische Klinik, Johannes Gutenberg-Universitaet, Mainz, Germany. r.meyer@3-med.klinik.uni-mainz.de
Vaccine ; 25(24): 4715-22, 2007 Jun 11.
Article en En | MEDLINE | ID: mdl-17499403
ABSTRACT
We identified a modified vaccinia virus Ankara (MVA)-peptide recognized by T cells of a vaccinated patient, applying a modified expression-based procedure. CD8(+) T cells reactive with MVA were expanded from peripheral blood of a patient after MVA-vaccination. The restricting HLA-elements and the antigen were determined applying stably HLA-class I-transfected K562 cells that were either infected wit MVA or transfected with a panel of MVA open reading frames (ORF). The T cells recognized the ORF 28R (K7R) gene product in association with HLA-B*1501 and the peptide-coding region was localized applying truncated in vitro transcribed mRNA. The 9-mer peptide encoded (ORF 28(25-33), SIIDLIDEY) was identified that was also recognized by ex vivo CD8(+) T cells from the patient and further healthy individuals.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus Vaccinia / Antígenos HLA-B / Epítopos de Linfocito T / Antígenos Virales Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Vaccine Año: 2007 Tipo del documento: Article País de afiliación: Alemania
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus Vaccinia / Antígenos HLA-B / Epítopos de Linfocito T / Antígenos Virales Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Vaccine Año: 2007 Tipo del documento: Article País de afiliación: Alemania
...